Apolipoprotein E in progressive supranuclear palsy in Japan

Molecular Psychiatry

Volumn 2, Issue 4, 1997, Pages 341-342

  Sawa, A ^a   Amano, N ^a   Yamada, N ^b   Kajio, H ^b   Yagishita, S ^c   Takahashi, T ^d   Oda, M ^e   Arai, N ^f   Ikeda, K ^f   Tadokoro, M ^g   Matsushita, M ^a  

^a Department of Neuropsychiatry ^*  (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAGAWA REHABILITATION CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer; Apolipoprotein E; Progressive supranuclear palsy (PSP)

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; CLINICAL GENETICS; CONTROLLED STUDY; CYTOSKELETON; DEGENERATIVE DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RISK FACTOR;

EID: 9844259478     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000285     Document Type: Article

References (16)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-359.
2. Hauw J-J, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. Preliminary MINDS neuropathologic criteria for Steel-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
3. Tabaton M, Rolleri M, Masturzo P, Cammarata S, Angelini G, Hansen LA, Saito T, Petersen RB, Perry G, Richey P, Gambetti P, Bertolini S. Apolipoprotein E ε4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995; 45: 1764-1765.
4. Schneider JA, Gearing M, Robbins RS, de l'Aune W, Mirra SS. Apolipoprotein E genotype in diverse neurodegenerative disorder. Ann Neurol 1995; 38: 131-135.
5. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzhnimer's disease. Lancet 1993; 342: 737-738.
6. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991; 541: 163-166.
7. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familiar Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
8. Joachim GL, Morris JH, Kosik KS, Selkoe DJ. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Ann Neural 1987; 22: 514-520.
9. Iwatsubo T, Hasegawa M. Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologic disease share common phosphorylation characteristic. Acta Neuropathol 1994; 88: 129-136.
10. Ma J, Yee A, Brwer Jr HB, Das S, Potter H. Amyloid-associated proteins a1-antichymotypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994; 372: 92-94.
11. Muramatsu T, Higuchi S, Arai H, Sasaki H, Yamada K, Hayashida M, Trojanowski JQ. Apolipoprotein E ε4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 1994; 36: 797-799.
12. van Duijn CM, Knijff P, Wehnert A, Voecht JD, Bronzova JB, Havekes LM, Hofman A, Broeckhoven CV. The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37: 605-610.
13. Benjamin R, Leake A, McArthur FK, Ince PG, Candy JM, Edwardson JA, Morris CM, Bjertness E. Protective effect of apoE epsilon 2 in Alzheimer's disease. Lancet 1994; 344: 473.
14. Ikeda K, Akiyama H, Arai T, Sahara N, Mori H, Usami M, Sakata M, Mizutani T, Wakabayashi K, Takahashi H. A subset of senile dementia with high incidence of the ApoE ε2 allele. Ann Neurol (in press).
15. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols: a Guide to Methods and Applications. Academic Press: San Diego, 1990, pp 153-158.
16. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990; 31: 545-548.